Novo Nordisk A/S
The Senior Manager, Medical Science Liaison leads the field team to execute Novo's cardiometabolic medical strategy across Ontario and Quebec. This role involves coaching Medical Science Liaisons, building relationships with key opinion leaders, and ensuring field insights inform medical and business decisions. The position requires strong leadership, scientific expertise, and a deep understanding of the Canadian healthcare landscape.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Cardiometabolic/Obesity/Renal/Endocrinology (CORE) Medical Science Liaison (MSL)
Azurity Pharmaceuticals
Regional Medical Science Liaison Director (RMD), Immunology – East
Celldex Therapeutics
Medical Science Liaison
Kardigan
Medical Science Liaison
Kardigan
Cardiometabolic/Obesity/Renal/Endocrinology (CORE) Medical Science Liaison (MSL)
Azurity Pharmaceuticals
Senior Medical Science Liaison
Definium Therapeutics